Clinical Trial Update: Study of Dehydroepiandrosterone Treatment for Poor Responders in In Vitro Fertilization Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing dehydroepiandrosterone for poor responders in IVF; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Dehydroepiandrosterone (dehydroepiandrosterone)

Snippet

Sponsor: KK Women's and Children's Hospital | Conditions: Infertility, Poor Responder to IVF Treatment | Phase 3 | Status: COMPLETED